Username:
Password:
   
Create an Account
 
Account
Curriculum
Transcript
Preferences
 
Welcome & Mission Statement
FAQs
User Technical Support
Accreditation Legend
System Requirements
 
AAMC CME
ABMS
ACCME
AHRQ
AMA
CDC
MBC
 
This activity already occurred and is no longer available.
The Glass is Half Full: Smoking Cessation for Smokers with Opioid Use Disorder
The UCSF Smoking Cessation Leadership Center (SCLC) presented this webinar on April 9, 2019 at 2:00 pm Eastern Time / 11:00 am Pacific Time (60 minutes).

   





The Glass is Half Full: Smoking Cessation for Smokers with Opioid Use Disorder 

presented by:

Shadi Nahvi, MD, MS
Associate Professor, Departments of Medicine, and of Psychiatry & Behavioral Sciences
Albert Einstein College of Medicine / Montefiore Health System
Bronx, New York

 

 Kimber P. Richter, PhD, MPH, NCTTP
Joy McCann Professor of Women in Medicine & Science
Department of Preventive Medicine and Public Health
University of Kansas School of Medicine
Kansas City, Kansas


The Smoking Cessation Leadership Center (SCLC) hosted this webinar on April 9, 2019 at 11:00 am Pacific time (60 minutes). You may claim CME credit here for your participation after the webinar has concluded. 

Educational Goals

This webinar will guide clinical skills development in the evidence-based treatment of tobacco use among persons with opioid use disorder, and increase provider knowledge about cessation treatment options to guide future clinical practice.

Learning Objectives

At the end of this activity, the participant should be able to:

  1. Use two evidence-based behavioral and pharmacological tobacco cessation treatments;
  2. Describe three strategies to address tobacco use among persons with opioid use disorder;
  3. Optimize two cessation treatments to enhance efficacy among persons with opioid use disorder.

Topics

This 60-minute webinar will address the following high-level topics. (More details can be found in the downloadable syllabus.)

  1. Health burden of tobacco use among persons with opioid use disorder (OUD)
  2. Evidence based behavioral smoking cessation treatments
  3. Evidence based pharmacological smoking cessation treatments


You will need a CMECalifornia (UC Online) account to register and claim CME credit for this activity.

If you do not already have an account with CMECalifornia.com, please click Create an Account to establish one.  You may then login with your email address and password.

You will receive an access code upon verification of your participation.  Use the access code provided by the host to proceed in claiming credit.

The fee to register for and claim CE credit is $45.  For a limited time, use the discount code SAMHSA23 to receive free CE credit, courtesy of the Smoking Cessation Leadership Center.

Cancellations and Refunds: Cancellations should be made in writing within 7 days of enrollment. Refunds will only be made in the event that technical difficulties prevent completion of the activity, or if no interaction with the material occurred because of inadvertent or mistaken enrollment, or expiration of the activity before the learner had the opportunity to complete it fully. Fees can be transferred to another activity in the case of mistaken enrollment.

Special Needs or Other Concerns: If you require any special accommodations for a disability which creates a hardship to participating in this activity, or you have questions or concerns about this course, please contact the Office of CME. (Additional contact information is below.)



Claiming your Credit

To obtain CME credit, participants must attend the entire webinar and complete a short evaluation survey.  Your certificate will be available immediately for print or download upon completion of the entire activity.  The estimated time to complete this live web activity is 60 minutes, which is equivalent to 1.0 credit. 

Disclosure

This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.
 
All planning committee members and reviewers have disclosed they have no relevant financial interest/arrangement or affiliation with any commercial companies who provide products or services relating to their presentation(s) in this continuing medical education activity.
Christine Cheng
Brian Clark
Jennifer Lucero, MA, MS
Kimber P. Richter, PhD, MPH, NCTTP
 
Jennifer Matekuare
Jessica Safier
Catherine Saucedo
Steven A. Schroeder, MD

The faculty speaker has disclosed a financial interest/arrangement or affiliation with a commercial company who has provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity. All conflicts of interest have been resolved in accordance with the ACCME Standards for Commercial Support:

Shadi Nahvi, MD, MS – Pfizer: Grant/Research Support

CAMFT-Certified Education Ethics Policy

No instructor or facilitator is permitted to promote or advocate for a single modality of treatment that is discriminatory or likely to harm clients, based upon current accepted standards of practice. All CAMFT-certified education must provide training on how to treat all clients in an ethically and clinically sound manner.





Accreditation

The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians
UCSF designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Registered Nurses:
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME.

Physician Assistants:
The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.

California Pharmacists:
The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 credit™. If you are a pharmacist in another state, you should check with your state board for approval of this credit.

Behavioral Health:
The University of California, San Francisco School of Medicine (UCSF) is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for Licensed Clinical Social Workers (LCSW), Licensed Clinical Marriage and Family Therapists (LMFT), Licensed Professional Clinical Counselor (LPCC) and Licensed Educational Psychologists (LEP). UCSF maintains responsibility for this program/course and its content.

This course meets the qualifications for 1.0 hours of continuing education credit for LMFT's, LCSW's, LPCC's and/or LEP's as required by the California Board of Behavioral Sciences.

Provider #64239.


Supplemental Material

Cultural and Linguistic Competency Resources  
CLC Info and Resources

UC Online Privacy Policy 
http://meded.ucsf.edu/cme/privacy-policy



------------------------------------------------------------------------------------------------------------




UCSF School of Medicine
Office of Continuing Medical Education
3333 California Street, Suite 450
San Francisco, CA  94118

info@ocme.ucsf.edu
Phone: (415) 476-4251 • Fax: (415) 476-0318




Type:     Internet Live Course
88 Registered Users